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Re-occlusion of arteries following percutaneous transluminal coronary angioplasty
(PTCA) remains a post-operative issue in the treatment of artery blockage. This re-
narrowing of the luminal cavity, a condition called restenosis, has been attributed to the
injury induced by PTCA balloon insertion. While arterial recoil can be completely
prevented by a coronary stent, this device is ineffective in halting neointimal hyperplasia
or vascular remodeling. However, recent studies have demonstrated that stenting in
conjunction with radiation therapy to the injured artery can reduce smooth muscle cell
(SMC) proliferation and the subsequent effects of the added extracellular matrix. Human
and animal trial studies have shown that 32P ion-implanted stainless steel stents are
effective in reducing restenosis.
Concerns regarding a non-uniform dose distribution from the short-range beta
particles emitted from a stent's open geometry have resulted in the development of
techniques to adequately determine stent surface activity distributions. Current methods
rely on autoradiographic techniques using radiochromic foil exposure analysis. The
purpose of this research was to determine the efficacy of employing electronically based
detection methods for determining activity uniformity rather than foil exposure. A highly
collimated solid organic scintillating plastic was optically coupled to a photomultiplier
Redacted for Privacytube in order to detect beta emission from selected surface regions ofa neutron-activated
31 6L stainless steel Guidant Multi1ink' stent. Irradiation of the stent activatedMn,
producing high energy, beta-emitting 56Mn as a substitute for 32P. Both Monte Carlo
computer modeling and experimental results demonstrated that inconsistencies in activity
attributed to stent geometry could be detected.
Because a stent is comprised of repeating structures, this technique may be used to
detect deficiencies in activity not associated with the predicted irregularities of activity
caused by geometry. Such a detection device may be more appropriate and efficient in
the industrial setting for quality assurance than current techniques using radiochromic
film exposure.©Copyright by Joshua I Bergman
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INTRODUCTION
Restenosis
Artery blockage, found mostly in the aorta and coronary arteries, is the result of an
accumulation of low-density lipoproteins (LDLs) following damage to interior vessel
tissue. Percutaneous transluminal coronary angioplasty (PTCA) is a common therapy
for alleviating symptoms arising from artery obstruction. This technique increases the
inner arterial diameter by compacting atherosclerotic plaques into the luminal wall by
the inflation of an inserted balloon. The balloon is attached to a catheter that can be
inserted into the artery from a location away from the chest cavity, typically the femoral
artery, eliminating the risks of open-heart surgery (1). However, re-occlusion of an
artery following PTCA remains a post-operative issue in the treatment of heart disease.
This re-narrowing of the luminal cavity, a condition called restenosis, has been
attributed to the injury induced by PTCA balloon insertion. The deleterious effect of the
injury is essentially the scarring of the vessel wall. Restenosis is the result of three
sequential factors stemming from PTCA: elastic recoil, neointimal hyperplasia, and
vascular remodeling. Elastic recoil is an immediate response of the treated artery to
balloon expansion, after which the inner diameter of the formerly stretched artery
decreases following balloon removal. The stretching of the artery resulting from elasticrecoil promotes proliferation and migration of smooth muscle cells (SMCs) to the site of
damage (2). Accompanying the proliferation of SMCs is the remodeling of the vessel
through the formation of an extracellular matrix (3).
Arterial Stenting
Arterial recoil can be completely prevented by a coronary stent, although this
device is ineffective for halting neointimal hyperplasia or vascular remodeling. The
stent provides scaffolding for the vessel wall, preventing decrease of the luminal
diameter. Conversely, a stent may actually provoke further hyperplasia resulting in a
higher degree of restenosis as proliferating cells migrate through the open geometry of
the stent structure (4). The stent itself may be composed of a singular wire coil, a slotted
tube, or a wire mesh tube. Emplacement of the stent into the artery is achieved by
mounting the stent over an angioplasty balloon deployed by a catheter. Inflation of the
balloon opens the stent to the diameter of the vessel, permanently anchoring it to the
interior vessel wall. The presence of the stent, like the angioplasty balloon prior, may
stimulate SMC migration. However, recent studies have demonstrated that stenting in
conjunction with radiation therapy to the injured artery can reduce SMC proliferation
and the subsequent effects of the extracellular matrix.
For radioactive stent applications, the desirable radiation type should be short-
range, only delivering dose to the tissue of the artery, e.g., beta particles, positrons, or
alpha particles. Delivery of radiation can be accomplished by a variety of methods.
One technique involves filling the deployment balloon with a radioactive liquid such as
188Re or 90Y, delivering the dose during stent placement (5). A similar method employsa brachytherapy seed injected into the stent via catheterization (6). External x-rays have
also been tested to eliminate restenosis; however, this technique will contribute dose to
anatomy other than the target tissue (3,7).
Direct irradiation of the stent material through neutron or proton bombardment is a
relatively simple method for producing a radioactive stent. Unfortunately, inherent
elements comprising the stent material may emit unwanted radiation such as gamma
radiation after activation. A solution to this dilemma is the process of ion-implantation
of radioactive phosphorus (32P), a pure beta emitter, into the stent surface. The
relatively short ranges of beta particles limits dose deposition to only the artery,
effectively inhibiting SMC proliferation through cell death.4
LITERATURE REVIEW
Stent Activation and Activity Measurement
Production of radioactivity in a metallic stent has been accomplished by a variety
of methods. One activation technique involves bombarding the stent with accelerated
charged particles. In a specific case where a Palmaz-Schatz stent constructed of
stainless steel was activated by an external beam of deuterons with subsequent proton
bombardment in the cyclotron located at the Nuclear Research Center in Karlsruhe,
Germany, activation created a mixture of radioisotopes from the main constituents of the
alloy. Specifically, these radioisotopes were 55Co (main activity), 56Co, 51Cr, 52Mn, 57Ni,
and 55Fe (8). The resulting radiation emitted from the metal was a combination of beta
particles, positrons, gamma rays, and x-rays produced following electron capture, with
half-lives ranging from 17.5 hours for 55Co to 2.7 years for 55Fe. Two total activities
were produced: 17.5 and 35 pCi. Dose measurements in this experiment were obtained
using LiF (Mg/Ti-doped) thermoluminescent dosimeters (3 x 3 x 1 mm) embedded
radially from the stent at different distances in a phantom composed of a polyamide.
Stents composed of titanium or nitinol (TiNi) also have been activated by proton
bombardment to produce 13.5pCiof the radioisotope 48V (15.98 day half life) in the
stent metal by the 47Ti(p,y)48V reaction (9). The 0.694 MeV maximum, -O.463 MeV
average energy positron emitted by 48V in addition to the relatively short half life makes
this technique ideal for radioactive stent therapy. However, the high energy gamma rays
of 48V and the x-rays generated by electron capture in 49V [49Ti(p,y) 49V; half life of 337
days] could introduce unwanted dose in organs other than the stented artery. Thepenetrating gamma rays and x-rays also present concerns related to safe handling of the
stent prior to arterial insertion.
Titanium wires of a braided stent ion implanted with phosphorus (into the first
one-third micron) have been irradiated with thermal neutrons to produce the
radioisotope 32P (3). Less than 0.01% of 31P went to 32P and no other long-lived
radioisotopes besides 32P (14.28 day half life) were found in the stent according to
spectroscopic measurements. Activities ranging from 0.047 to 0.060 iiCi were
determined at the time of initial ion implantation after the stents were placed in the
chamber of a gas-filled proportional counter (4ir geometry) calibrated previously with
known sources of activity.
In another method, 20 mg of red amorphous phosphorus was first irradiated for
-P10 days achieving a concentration of 2.0 x i032P/31P with thermal neutrons at the
research reactor in Petten, Netherlands. The irradiated phosphorus was ionized in the
Nielson ion source of the Karlsruhe, Germany mass separator and accelerated to an
energy of 60 keV (10). A magnet separated the31P from the 32P, after which the 32P was
then implanted into the first 35 nm of the surface of a stainless steel Palmaz-Schatz
stent. A germanium radiation detector measuring induced bremsstrahlung in copper and
tungsten analyzed activity levels of each stent. Autoradiographic techniques were used
to evaluate the homogeneity in activity distribution on each stent. Two activities of 4.2
± 0.2 and 13 ± 0.2 iCi were used in this study. The detection system was calibrated
using a 4it liquid scintillation detector to measure absolute beta activities.Radioactive Phosphorus
The characteristics of radioactive phosphorus make it an excellent choice for
treating restenosis. Phosphorus only exists in nature as the 31P isotope (100% abundant)
and therefore irradiation with thermal neutrons will only create the radioisotope 32P, a
pure beta-particle emitter. Furthermore, the decay product of 32P is 32S, a stable element.
The energy spectrum of the beta particles ranges from zero to a maximum of 1.709 MeV
with an average energy approximately one-third of the maximum. The only other
accompanying radiation associated with the beta radiation may be bremsstrahlung
photons generated by beta particles interacting with high Z elements in the stainless
steel. Probability of interaction for these highly penetrating photons with the vessel
tissue is small, while the maximum dose deposition from beta-particle interaction occurs
only in the first few millimeters of the vessel wall (11).
Trial Studies
A study involving New Zealand White rabbits implanted with radioactive stents
did not display evidence of arterial radiation damage up to one year (8). Also, the Phase-
1 isostent for restenosis intervention study (IRIS), a clinical human trial for 32P-
implanted radioactive stents, exhibited no indication of revascularization within the
stented artery within the first 30 days (12). However, a continuation of this study in
Milan, Italy showed that after six months from receiving a 32P-implanted stent with
activities ranging from 0.75 to 12.0 j.tCi, 41% to 52% of the patients were found to have
restenosis around the edges of the stent (13,14). Total doses ranged from -8 Gy to 140
Gy over a 28 day period to tissue 0.5 mm from the stent surface for the correspondingactivity levels. Several suggestions have been presented regarding the cause of what has
been named the "edge effect." The most probable basis for this restenosis after
radioactive stent emplacement is a lower dose of radiation received by tissue at the stent
edge. In this location, injured tissue attempting to repair (leading to restenosis) may not
be affected by radiation if lesions are beyond the first 1 to 3 mm from the stent edge. In
contrast, it was found that at the higher administered activity levels, restenosis did not
occur within the stent. This may be explained by the reasoning that within the first 14
day half life for 32P, rapidly dividing SMCs are in a more radiosensitive phase of the cell
cycle. After this initial reduction in the proliferating cell population during the critical
mitotic stage of cell division, the ability for continued repair is severely limited unless
the injury is repeated (3).
A utoradiographic Dose Determination
Analysis of exposed radiochromic dye foils is a proven technique for determining
doses from both particle and electromagnetic radiation. The "foil" is essentially an
emulsion-coated film whose optical density alters in areas of radiation exposure (darker
where radiation has exposed the film, lighter where it has not), much like photographic
film used in cameras exposed to visible light. Dose can be measured by scanning the
foil with a spectrophotometer or densitometer and comparing the readout with a
previously calibrated foil exposed to a source with a known dose rate in the medium of
interest. Soares and McLaughlin (15) have developed a novel high-resolution
radiochromic foil (GafChromicml Dosimetry Medium) designed for use with small beta-
particle emitters such as brachytherapy seeds. GafChromic' Dosimetry Medium hasalso been used in determining dose from radioactive stents(5,16).Although the
emulsion is initially colorless, it will turn blue in areas of radiation exposure. To
measure optical density, this study employed a scanning HeNe laser densitometer having
a spot-size diameter of 100 J.tm with scanning-step intervals of 40 tm both horizontally
and vertically. Differences in optical density for this particular film are linearly
proportional to absorbed dose from 10 to 1000 Gy, and image production does not
require post-exposure image developing, unlike many other radiochromic foils. Despite
this advantage, Soares and McLaughlin report that the image "stabilizes a few days after
exposure." It can be inferred that even though the need for film processing is removed,
time saved may be limited.
The study presented conclusive data that 90Srf°Y sources measured on contact
with GafChromicfilm are corroborated by similar measurements made by the U.S.
National Institute of Standards and Technology (NIST). However, there are a number
issues to be considered that may limit the accuracy of data analysis:
1. Emulsifier coatings can vary, affecting the sensitivities of the foil from batch to
batch.
2. Temperature arid humidity may affect the developing image.
3. Effects of electron energy and/or dose rate to the calibration curve are currently
unknown.
Finally, Soares and McLaughlin state that "for total doses below about50Gy poor
signal to noise characteristics are exhibited, while foils exposed to total doses above
about1500Gy are of too high a density to be read reliably due to low light transmission.To extend the foil dynamic range, it is necessary to make several different exposures for
widely different times."
An issue that has yet to be addressed is the fact that doses from some
implanted stents are lower than 50 Gy. As mentioned previously, application of
GafChromicfilm for radioactive stent dosimetry already has been in use. However,
future use of this autoradiographic medium will necessitate careful data interpretation in
light of the foil's dosimetric limitations.
Because of the apparent constraints of the aforementioned audioradiographic
techniques, the objective of this thesis was to provide an investigation of the possibility
of introducing a new form of detection for radioactive stents. Specifically, the main
focus here was to determine if employing solid organic scintillation techniques is an
appropriate method for evaluating the uniformity of activity along the surface of a stent.
The first portion of this work consisted of calculating differences in energy
deposition in a detector from a modeled stent using Monte Carlo techniques, specifically
the computer code MCNP (Monte Carlo N-Particle) developed at Los Alamos National
Laboratory (17). This modeling provided information regarding the amount of
collimation required for the detector to discriminate between different areas of the stent.
The modeling also provided the necessary geometry of the detector's sensitive volume
to collect only beta particles emitted from the stent but not bremsstrahlung photons
resulting from electron interactions within the collimator. The effect of stent geometry
on spatial activity variation was also considered. The completed MCNP model was used
to construct a detection system with the ability to detect high-energy beta particles
without signal interference from scattered photons (see Appendices A and B).10
METHODOLOGY
Stent Irradiation
Because of the limited availability of 32P ion-implanted stents, this experiment
employed a neutron irradiated 2.5 mg segment of a 3 16L stainless steel Guidant
Multilink' stent provided by NIST. Activation of the 100% abundant 55Mn within the
alloy produced 56Mn with an average beta energy of roughly 830 keY (100% branching
ratio) (18). Table 1 gives the weight fraction for the elemental constituents of 31 6L
stainless steel (19).
Table 1. 3 16L stainless steel composition (p=8.00 g cm3).
Element Weight Percent (%)
Iron 65.395
Chromium 17.000
Nickel 12.000
Molybdenum 2.500
Manganese 2.000
Silicon 1.000
Phosphorus 0.045
Carbon 0.030
Sulfur 0.030
The relatively large cross section of 55Mn (13.3 barns thermal, 14.0 barns
epithermal) and short half life of 56Mn (-2.6 h) allowed for a short irradiation time,
enabling the 56Mn activity to build up to a much higher value than the other isotopes of
the sample (20). The Oregon State University TRIGA reactor rabbit facility was used to
conduct a 2 minute irradiation at a 1 MW power level. The corresponding neutron flux
at 1 MW is 9 x1012ncm2s' thermal and 4 x 1011 ncrri2sepithermal. An activity of11
approximately 34 pCi was attained using this procedure. Previous irradiation of the
stent to 3.6 pCi and subsequent analysis of the emitted gamma radiation with a high
purity germanium (HPGe) detector and multichannel analyzer (MCA) demonstrated that
nearly all of the photon activity resulted from the
56decay. Figure 1 displays a
spectrum of the counts deposited into each channel of the MCA. The majority of the
counts resulted from 56Mn decay, evident from the 846.8 keV peak for the
corresponding gamma energy of 56Mn. The smaller peak at 192.2 keV for 59Fe shows
that despite the large percentage of iron composing the stent alloy, its relatively small
cross sections (1.2 barns thermal, 1.5 barns epithermal) compared to "Mn resulted in a
small contribution to the total activity.
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Fig. 1. Gamma spectrum of activated 31 6L stainless steel.Detection Techniques
A solid, vinyltoluene-based organic scintillating plastic fiber 1.6 cm long and 1
mm in diameter (donated by Bicron; model 6 12-00068 blue emitter) was embedded into
a 2 cm thick slab of Lucite. The Lucite was optically coupled to a 3-inch diameter
photomultiplier tube (PMT) with high-viscosity silicone grease. As shown in Figure 2,
the scintillating fiber was separated from the PMT with 0.4 cm of the Lucite slab. This
configuration permitted scintillation photons to be scattered uniformly across the face of
the PMT. Coating the outer surfaces of the Lucite slab with white paint also helped to
diffusely reflect photons laterally emitted by the scintillator into the PMT.
This particular solid scintillating medium provided the benefit of durability,
relatively fast resolving time (23-5 8 ns), and a high efficiency for beta detection.
Furthermore, the low atomic number of the scintillator plastic reduced bremsstrahlung
radiation production and kept the efficiency of detecting gamma radiation low. Plastic
scintillators are also easily shaped and inexpensive, requiring little maintenance as
compared to gas ionization detectors also applied in beta radiation detection (21).
Copper collimator
Light shield
Photomultiplier Tube
/Mounted stent
Fig. 2. Detection system and mounted stent.
'ucite
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A 0.95 cm thick copper slab with a 1 mm diameter collimator was mounted directly
above the scintillating fiber. A light-tight box of black tape and black paper surrounded
the detector, preventing ambient light from entering the scintillator or PMT (see
Appendix C for images of detection system). The collimator opening on the side of the
scintillating fiber was covered with black tape to block light from entering the
scintillator through the collimator. However, the tape was thin enough for beta particles
to penetrate. Table 2 provides the ranges of the beta particle at the maximum and
average energy for various materials used in the experiment.
Table 2. Beta particle ranges for 56Mn
Ranges(Cffl)a
Material Ep(max.)=2.84 MeV Ep(ave.)=0.830 MeV
Lucite 1.24 0.300
Copper 0.147 0.0566
Scintillation Plastic 1.41 0.339
Air l.30x103 3.23xl02
Tissue 1.44 0.347
°Values obtained from NIST.
The detector was operated at 1075 V in conjunction with a single channel analyzer
having a lower level window of 0.3 V and a 10 V upper level window. These settings
minimized the number of counts resulting from electronic noise without reducing the
number of counts attributed to scintillation events. Figure 3 verifies that the electronic
noise (essentially the background for this detector) made an insignificant contribution to
the total number of counts recorded by the detector. Counts were taken over 5 minute
intervals for SCA window widths of 0.1 volts (normal mode to record data shown in
Figure 3).14
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Figure 3. Gross counts as a function of the voltage window. The triangles represent the
total counts taken with the activated stent (sample + background), the circles represent
only background counts, and the squares represent the net counts.
The activated stent (wall thickness -.0. 1 mm) was expanded onto a beveled steel
rod 2.5 mm in diameter centered 1.5 mm over the collimator with a device that allowed
the stent to be axially rotated. A beta shield consisting of 2.54 cm thick Lucite was
positioned over the stent to reduce beta dose to the eyes and upper extremities of the
experimenter.
To attain the activity level consistent with typical radioactive stents, the sample
was allowed to decay for a period of 9.5 hours. At 2.64 tCi, counts were collected over
10 minute intervals. After each time interval, the stent was manually rotated 30 degrees
(to prevent overlapping counting areas) along the center axis until one full rotation was
completed. Counts were decay corrected for the duration of the counting time to
account for the short half life of 56Mn.15
RESULTS AND DISCUSSION
As stated previously, the purpose of this study was to determine if differences in
activity along a radioactive stent could be detected using solid organic scintillation
techniques. It should be noted that the degree of sensitivity the detector must have to
distinguish one region of the stent from another is directly related to the diameter of the
collimator. For a non-expanded stent, the 1 mm diameter used in this study would not
be small enough for the detector to recognize slight changes in the activity distribution.
However, expanding the stent for this experiment resulted in a very open geometry with
distances between the structural units as large as 1 mm.
The MCNP-modeled detection system, from which the experimental design
originated, showed that pulses yielded from the scintillating plastic fiber resulted from
mainly the beta particles emitted from the source (the stent source used in MCNP was
modeled after the geometry of the Guidant Multilinkml stent used in the experiment).
Table 3 shows from the MCNP calculations that very few bremsstrahlung and other
created photons deposited energy into the scintillator as a result of beta interaction with
the detector. The MCNP model verified the assumption that a relatively long, thin
cylinder for the sensitive volume of the detector would be most sensitive to beta
particles emitted from the source.
Table 3. MCNP-modeled radiation interactions with detection system.
Particle Tracks Entering Selected Cells
Cell Created Photons Source Betas
Scintilator 35 443
Collimator 11093 262759
Lucite 1075 386A comparison was made between the weighted average of the experimental and
MCNP net count rates and the individual net count rates as a function of radial position
(see Table 4). The weighted mean for the net experimental count rate was 78.7 ± 0.9
and 1565 ±49 for the MCNP calculations. Equations 1 and 2 below were used to find
the weighted average and standard deviation of the weighted average, respectively.
_i=1°j
i=1cr
1/2
1 1
XIj
'cJJ i=1
16
(1)
(2)
Table 4. Variation in activity (as determined from net count rate) as a function of radial
position.
Radial Position %Ratio to Weighted Meana %Ratio to Weighted Meana
(degrees) (experimental) (MCNP)
0 79.5±3.5 90.8±0.5
30 82.5±3.6
60 84.0±3.6 112.0±0.6
90 108.8±4.1 -
120 102.3±4.0 90.8±0.5
150 116.1±4.2 -
180 129.8±4.5 112.0±0.6
210 104.9±4.0 -
240 88.3±3.7 90.8±0.5
270 98.3±3.9 -
300 103.2±4.0 112.0±0.6
330 130.1±4.5 -
allote that the radial orientation of the stent during the experiment did not necessarily correspond to the
orientation for the MCNP calculation. Thus data at a given radial position should not necessarily match.
Rather, the purpose of this table is to illustrate the degree of variability in dose delivered from various
regions of the stent.17
Figures 3 (a) and (b) show a comparison between the measured variations in
MCNP and the actual variations in net counts per minute measured with the detector as a
function of angular orientation about the stent axis. The measured background was 44
counts in 10 minutes.
Figure 3 (a) shows the modeled regular activity variation from the stent strut
geometry. This variation is the result of the placement of structural elements required
for the stent to maintain its form while propping open an artery. Although the data
obtained from the experiment do not exactly match the modeled stent, it is evident from
Figure 3 (b) that the detector exhibited the ability to differentiate between zones of lower
and higher activity with noticeable differences.
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Fig. 3. Variations in MCNP modeled net count rate from stent as a function of radial
position measured in degrees (a) and variations in experiment net count rate from stent
as a function of radial position measured in degrees (b).18
Closer inspection of the mounted stent showed that expansion of the struts had not
occurred evenly. This may be the reason for the depression in relative activity of the
experimental data, e.g., at00,30°, and 60°, compared to the MCNP model. A similar
situation involving non-uniform expansion has been reported by Janicki et al. (22). It
can be concluded from these results that a non-uniform dose up to -3O% can occur from
asymmetrical geometry of the stent structural units even though the activity of the stent
material is uniform.
The wide disparity between the MCNP-calculated count rate and the measured
experimental count rate may be the result of the energy cut-off by the lower level
window of the single channel analyzer in the experimental data. The difference may
also be the result of MCNP 's inability to model the light collection efficiency of the
PMT. Although the code may accurately model the energy distribution of pulses created
in the detector, it cannot model the number of light pulses that eventually reach the face
of the PMT. Furthermore, there is a limited conversion efficiency for the number of
photoelectrons produced after the interaction of the scintillation light within the PMT's
photocathode. These discrepancies, however, do not affect the percent variation as a
function of the stent's radial position.19
CONCLUSIONS
The work presented here has shown that an alternative and perhaps superior
method for determining activity distribution on a small beta-emitting source may be
found using a solid organic scintillation technique, as opposed to autoradiography with
radiochromic films. The detection system used in this study could be modified such that
the stent is automatically positioned both angularly and linearly. Counts measured at
different locations along the stent could then be used to construct a three-dimensional
map of the activity distribution. Determining the shortest counting time and a count rate
to dose rate conversion factor would further enhance this technique, essentially creating
a one step process for evaluating the radiation-related characteristics of a stent.
Finer resolution may also be attained with smaller diameters of the collimator
opening, although counting statistics may suffer accordingly. This fmer resolution
would be important for small radiotherapeutic devices such as brachytherapy seeds.
Using this technique for a non-expanded stent prior to arterial insertion would also
require a small diameter collimator; however, no determination has been made regarding
the minimum loss of areal activity along the stent that would hinder the dose required to
prevent restenosis.
Use of ion implanted alpha emitting isotopes could also be an alternative to beta-
emitting isotopes. However, the shorter range of the alphas could perturb edge effects
and require a more closed stent structure that could compromise flexibility.
These findings bring to light the important fact that radioactive stents are only as
effective in preventing restenosis as the near-field dose distribution created around them.20
This issue has been demonstrated in the previously discussed "edge effects" found to
occur with current 32P ion implanted stents. Future stent design may necessitate a
structure that renders a more uniform dose field, therefore requiring a more uniform
activity.21
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Appendix A MCNP Modeling
MCNP Modeling Overview
MCNP is a computer program that models sources of radiation and the interaction
of radiation with matter using Monte Carlo methods. Monte Carlo is a technique of
mathematically simulating a statistical process, such as the transport of radiation through
materials. Random numbers are generated to sample probability distributions that
govern a given natural process for individual particles. By randomly sampling these
distributions many times for each particle, it is possible to obtain a statistically accurate
approximation of the modeled scenario. For MCNP, this could describe the transport of
an electron emitted from a radioactive stent through an arterial vessel wall. Certain
physical laws dictate in what manner the electron will interact with the tissue in real life.
Depending upon the characteristics of the electron, e.g. energy, the specific interaction
in MCNP will occur based on empirically derived statistical probability distributions and
transport data. The Monte Carlo process basically follows the "random walk" of each
particle to its point of termination. Application of the Monte Carlo method to many
particles provides a very realistic depiction of the eventual fate of these particles.
MCNP is a very capable tool for determining the effectiveness of shielding
materials against basic forms of ionizing radiation (photons, electrons, and neutrons),
providing acquired dose estimates in any material, and calculating the amount of energy
deposited in the sensitive volume of a detector. It is also very useful in performing
nuclear criticality calculations. Apart from the ability of MCNP to simulate radiation
sources, it can also geometrically model a number of basic three-dimensional shapes in a25
three-dimensional coordinate system. Furthermore, these geometrical formscan be
modified and combined using Boolean logic operators. Structures that are created in
MCNP are composed of cells in which interactions are calculated and tallied by the
code. The composition of each cell is limited to only one homogeneous material;
however, materials are described based on weight (or atomic) fractions of elements,
enabling the user to specify the constituents of any conceivable substance.
Source geometry in MCNP is limited either to three volume distributions
(Cartesian, spherical, and cylindrical) or three surface distributions on these shapes.
Degenerate forms of the spherical and cylindrical geometry types will produce point and
line sources, respectively. Slightly more complex sources can be defined by combining
these shapes. It is also possible to describe a cell or set of cells from the problem
geometry as a source. This is achieved by encasing the cell(s) within a source volume
distribution and directing MCNP to sample only cells within that source geometry for a
given probability. The advantages of using a cell distribution for the source emerge at
times when the source being modeled has a shape that can not be modeled in the source
defmition. As MCNP samples the source volume, it will only accept points that are also
found in the cell(s) inside the source volume.
Stent and Detector Modeling
A single strut was modeled in MCNP by intersecting a hollow stainless steel
cylinder with several planes to essentially "cut out" the structure. An entire stentwas
then generated by radially and longitudinally repeating the initial segment. This feature
of MCNP is extremely useful for this type of application because the structure only26
needs to be defmed once and then can be copied in any orientation or location within the
model.
A simplification of the stent model was made to reduce the amount of
computational time required to accurately simulate the radioactive stent. The alternate
model consisted of only one circular section comprised of six strut segments of the stent.
This simplification of the stent to a singular circular segment can be justified by the fact
that the detector collimator diameter was less than the length and diameter of the stent
segment.
The collimator was constructed in MCNP as a 1.21 cm thick copper disk placed
1.5 min above the stent, having a 1.0 mm diameter opening. All computer simulations
were modeled in a standard temperature and pressure air environment. Low Z materials
are commonly the standard (and recommended) choice when shielding or collimating
beta radiation to avoid complications associated with bremsstrahlung production. Most
beta particles are also effectively stopped by a relatively small thickness (a few
millimeters, depending on the material and energy). It therefore appears that 9.5 mm
copper was an unnecessary material at a very unnecessary thickness. For a typical
shielding scenario, this would be true. However, the unique situation presented by the
necessity of scanning an extremely small radioactive source emitting high energy beta
particles lent itself to unorthodox approaches.
From a non-radiation standpoint, copper was desirable because of its low toxicity
and non-corrosiveness in the presence of oxygen. The latter factor is especially
important in regard to the small collimator opening that could easily become obstructed
and thereby greatly influence counting rates. The softness of lead and lower melting27
point would have complicated the process of drilling out the collimator and maintaining
the 1 mm diameter. Concerning radiation interactions, copper was still an acceptable
choice. The high density(8.96gcm3)provided a very tight and "clean" collimation so
that the measured count rate resulted only from betas emitted from the section of stent
directly beneath the collimator opening. Copper also has low levels of radioactive
impurities, unlike aluminum that has uranium and/or radium concentrations high enough
to warrant concern when counting low levels of radiation. The daughter products from
these radioisotopes emit a mix of alpha, beta and gamma radiation.
The thickness of the collimator was chosen so that only beta particles traveling in
the forward direction would be focused onto the detector face. The actual sensitive
volume of the detector was centered over the collimator aperture, and consisted of a
1.905cm long by 1 mm diameter vinyltoluene based plastic scintillating fiber. A disk of
1.905cm thick Lucite into which the fiber was embedded made direct contact with the
collimator.
MCNP not only has the capability to model an electron source, but also the
resulting photons and other scattered electrons. Information regarding the nature of
particles entering cells of the problem geometry is calculated by MCNP depending on
the type ofcell tallyspecified by the user. One or more cells of the problem geometry
can be specified to tally particles in a variety of ways within that cell, such as the flux
across the cell's surface. Apulse height tallyused in the model furnished the amount of
pulses deposited into the scintillating fiber from the source from both electron and
photon contributions, resulting in the simulation of a realistic detector.28
The small diameter of the scintillating fiber helped to reduce the photon
contribution of the total energy collected. In previous models, the scintillator plastic
occupied the entire space above the collimator. However, this arrangement resulted in
an energy deposition composed mostly of bremsstrahlung photon interactions in the
plastic, effectively masking any energy contribution made by the beta particles emitted
from the stent.
It should be noted that the transport of electrons introduces more computational
complexity for MCNP than for photons. For this reason, MCNP requires a large amount
of computing to time to generate results within acceptable confidence intervals.
The stent model presented an even greater challenge to the code's capabilities in
that the only electrons tallied were those which successfully entered the collimator and
deposited their energy into the detector. MCNP permits source variable biasing to
accelerate the calculations that determine the fate of transported electrons. Other
variance reduction techniques can be used in MCNP, but F8 tallies with energy bins are
limited to only source biasing. In the stent model, more electrons were emitted from the
source cell beneath the collimator than other source cells, but with a suitably reduced
weight for each biased particle. Consequentially, the effect of this variance reduction
technique provided good statistics with fewer histories and less computer time.29
Appendix B MCNP Input Files
MCNP Input File for Zero Degree Stent Rotation
1 Guidant stent, Beta Model (6/4/00) Josh Bergman
C Stent material: 316L Stainless Steel
C Detector facing chevron with strut connector: Activated Mn-56
C
C *0 degree rotation of stent*
C
1 3 -8.00 1-2 -3456(-8:-9:17)12 13-22 vol=4.8E-5
imp:e=l $-x
2 like 1 but TRCL=l vol=4.8E-5 imp:e=l
3 like 1 but TRCL=2 vol4.8E-5 imp:e=l
4 3 -8.00 1 -2 -3456(-8:-9:23)12 1322 vol=4.8E-5
imp:e=l $+x
5 like 4 but TRCL=5 vol=4.8E-5 imp:e=1
6 like 4 but TRCL=6 vol=4.8E-5 imp:e=l
7 3 -8.00 1-2 -34 -30 -31 (32:35) -36-39 vol=8.lE-5
imp:e=1 $Empty chev
8 like 7 but TRCL=3 vol=8.1E-5 imp:e=l
9 like 7 but TRCL=4 vol=8.1E-5 imp:e=1
10 2 -.00120479 -15 16 19 -18 #1 #2 #3 #4#5 #6 #7 #8 #9
vol=8.25E-4 imp:e=l $Air Cylinder
21 2 -.00120479 (15:18:-l9)(24:-27:20) -21vol=13l9 imp:e=l
22 021 imp:e=0 $Void
23 1 -7.82 -18 19 -16 imp:e=1 $Carbon steelguide rod
C Detector
24 5-1.032 -2926 -28 imp:e=1 $Sciritillating plastic
25 6-8.96 -2627 25 -24 imp:e=l $Copper Collimator
26 2-.00120479-25 -26 27 imp:e=l $Air in Collimator
27 4-1.19 -2026 -24 (28:29) imp:e=1 $Lucite around
scintillator
1 cx .125 $Inner cylinder of SS
2 cx .135 $Outer cylinder of SS
3 px .075 $lst Ring Plane
4 px -.035 $lst Ring Plane
5p000 -.0750 .0513 .141 .0750 .0513 .141 $Pos wedge plane
6 p000.0750 -.0513 .141 -.0750 -.0513 .141 $Neg wedge plane
c7 p0000.0455 .143 -.0650 0.150 $1 plane (3-point planes)
8p0000.0455 .143 .0650 0.150 $11 plane
9 p000.0663 0.150 0 -.0455 .143 $111 plane
c 10 p 0000 -.0455 .143 -.0650 0.150 $IV plane
c 11 p 000 -.00825 .0513 .141 -.0815 0.150 $1' plane
12 p000.00825 .0513 .141 .0815 0.150 $11' plane
13 p000.00825 -.0513 .141 .08150.150 $IIIt plane
c 14 p000 -.00825 -.0513 .141 -.0815 0.150 $IVt plane
17 p 0000 -.00518 .1349 .075 -.00518 .1349 $Strut connector
23 p0000.00518 .1349 .075 .00518 .1349 $Strut connector
22 py 0 $Strut connector plane
15 cx .1352 $Outer Air Cylinder
16 cx .1248 $Inner Air Cylinder/outer Air Cylinder for SS struts
18 px .0752 $Outer air plane
19 px -.0352 $Outer air plane
C Surface for empty chevrons-numbers in parentheses represent
cthe original surf.
30 p 000 -.0750 .0513 .141 .0750 .0513 .141 $Pos wedge(5)30
31 p000.0750 -.0513 .141 -.0750 -.0513 .141 $Neg wedge(6)
32 p0000.0455 .143 -.0650 0.150 $1 plane (3-point)(7)
c 33 p0000.0455 .143 .0650 0.150 $11 plane (8)
c 34 p000.0663 0.1500 -.0455 .143 $111 plane(9)
35 p0000 -.0455 .143 -.0650 0.150 $IV plane (10)
36 p000 -.00825 .0513 .141 -.0815 0.150 $1' plane (11)
c 37 p 000.00825 .0513 .141 .08150.150 $11' plane (12)
c 38 p 000.00825 -.0513 .141 .08150.150 $111' plane (13)
39 p000 -.00825 -.0513 .141 -.0815 0.150 $IV' plane (14)
21 so 7
C Collimator/Detector Surfaces
20 pz 3.0925 $Top of Lucite (3/4" = 1.905 cm thick)
24 c/z .03750 2.54 $Radius of collimator
Ito z-axis (x,y,R)
25 c/z .0375 0.05 $Rad of collimator openingi Ito z-axis (x,y,R)
26 pz 1.1875 $Division between scintillator and copper (3/8')
27 pz .235 $Copper collimator .08 cm above stent
28 c/z .0375 0.05 $Radius of scintillator IIto z-axis(x, y,R)
29 pz 2.775 $Top of scintillator (5/8"=1.5875 cm)
Mode P E
Phys:E 2.849 $Max energy cut-off for Mn-56 electrons (MeV)
imp:p 11111111111011111
C(x y z)(x,x' y,x' z,x')(x,y' y,y' z,y')(x,z' y,z' z,z')
C Cell translations in degrees (the asterisk)
C For cells 2 and 3
*TR1 000090 90 90 -120 210 90 -30 120
*TR2 000090 90 90 -240 330 90 -150 240
C For cells 8 and 9
*TR3 000090 90 90 -120 210 90 -30 120
*TR4000090 90 90 -240 -30 90 -150 240
C For cells 5 and 6
*TR5 000090 90 90 120 -210 -90 30 -120
*TR6 000090 90 90 240 -330 -90 150 -240
C Materials:
C Carbon Steel (Density=7.82 g/cm"3)
ml 6000.005 $C
26000 -.995 $Fe
CAir (Density=.00l20479 g/cm"3)
m2 6012.000124 $C
7000.755267 $N
8016.231781 $0
18000 -.012827 $Ar
CStainless steel tube-316L (Density=8.00 g/cm'3)
m3 6000 .0003 $C
25055 .02 $Mn
15031 .00045 $P
16000 .0003 $S
14000 .01 $Si
24000 .17 $Cr
28000 .12 $Ni
42000 .025 $Mo
26000 .65395 $Fe
CLucite (Density=l.l9 g/cm"3)
m4 1001.080538 $H
6012.599848 $C
8016.319614 $0
CPlastic Scintillator (Density=l.032 g/cm'3)
m5 1001.085 $H
6012.915 $C
CCopper (Density=8.96 g/cm"3)
m6 29000 -1 $Cu
SDEFERG=Dl
POS=0 0031
CEL=D2 $Source Cells
WGT=92500 $2.5 uCi (1/12 of stent), no competing rad.
PAR=3 $Particle number for electron
RAD=D3
EXT=D4
AXS=l 00
EFF=.005 $This determines source sampling efficiency
(lower limit); default=.0l
C A lower efficiency is needed for the source to work given its
C " o p e n
C geometry."
C Energies from Brown and Firestone, 1986
C Column 1: Energy bin boundaries; "h" for histogram
C Column 2: Relative intensities (%); "d" for discrete
# SIl SP1
h d
o 0
0.01 0.69
0.02 0.70
0.04 1.43
0.10 4.66
0.30 17.40
0.60 23.00
1.30 27.00
2.50 24.50
2.849 0.55
S12 L123456789 $Source cells
SP2 V 111111111$"V" used only for cell distributions
SB2 D511511111 $Source biasing option
S13 .12499999 .13500001 $Inner and outer radii
S14 -.03500001 .07500001 $- and + length of cylinder (x-axis)
F8:E 24
*F18:E 24
E80.01 2481 2.5 $Spectrum starting at 10 key to 2.5 MeV
NPS 100000032
MCNP Input File for Sixty Degree Stent Rotation
1 Guidant stent, Beta Model (6/4/00) Josh Bergman
C Stent material: 316L Stainless Steel
C Only one chevron facing detector: Activated Mn-56
C
C *60 degree rotation*
C
1 3 -8.00 1-2 -3456(-8:-9:17)12 13-22 vol=4.8E-5
imp:e=l $-x
2 like 1 but TRCL=l vol=4.8E-5 imp:e=l
3 like 1 but TRCL=2 vol=4.8E-5 imp:e=l
4 3 -8.00 1-2 -3456(-8:-9:23)12 1322 vol=4.8E-5
imp:e=l $+x
5 like 4 but TRCL5 vol=4.8E-5 imp:e=l
6 like 4 but TRCL=6 vol=4.8E-5 imp:e=1
7 3 -8.00 1-2 -34 -30 -31 (32:35) -36-39 vol=8.1E-5
imp:e=l $Empty chev
8 like 7 but TRCL=3 vol=8.1E-5 imp:e=1
9 like 7 but TRCL=4 vol=8.1E-5 imp:e=1
102 -.00120479 -15 1619-18 #1 #2 #3 #4#5 #6 #7 #8 #9
vol=8.25E-4 imp:e=1 $Air Cylinder
21 2 -.00120479 (15:18:-19)(24:27:-20) -21vol=1319 imp:e=1
22 021 imp:e=0 $Void
23 1 -7.82 -18 19 -16 imp:e=1 $Carbon steelguide rod
C Detector
24 5 -1.032 29 -26 -28 imp:e=l $Scintillating plastic
25 6 -8.96 26 -27 25 -24 imp:e=1 $Copper Collimator
26 2 -.00120479 -25 26 -27 imp:e=1 $Air in Collimator
27 4 -1.19 20 -26 -24 (28:-29) imp:e=l $Lucite around
$ scintillator
1 cx .125 $Inner cylinder of SS
2 cx .135 $Outer cylinder of SS
3 px .075 $lst Ring Plane
4 px -.035 $lst Ring Plane
5p000 -.0750 .0513 .141 .0750 .0513 .141 $Pos wedge plane
6 p000.0750 -.0513 .141 -.0750 -.0513 .141 $Neg wedge plane
c7 p0000.0455 .143 -.0650 0.150 $1 plane (3-point planes)
8p0000.0455 .143 .0650 0.150 $11 plane
9 p 000.0663 0.150 0 -.0455 .143 $111 plane
c 10 p0000 -.0455 .143 -.0650 0.150 $IV plane
c 11 p000 -.00825 .0513 .141 -.0815 0.150 $1' plane
12 p000.00825 .0513 .141 .08150.150 $11' plane
13 p000.00825 -.0513 .141 .08150.150 $111? plane
c 14 p000 -.00825 -.0513 .141 -.0815 0.150 $IV' plane
17 p0000 -.00518 .1349 .075 -.00518 .1349 $Strut connector
23 p0000.00518 .1349 .075 .00518 .1349 $Strut connector
22 py 0 $Strut connector plane
15 cx .1352 $Outer Air Cylinder
16 cx .1248 $Inner Air Cylinder/Outer Air Cylinder for SS struts
18 px .0752 $Outer air plane
19 px.0352 $Outer air plane
C Surface for empty chevrons-numbers in parentheses represent
cthe original surf.
30 p000 -.0750 .0513 .141 .0750 .0513 .141 $Pos wedge (5)
31 p000.0750 -.0513 .141 -.0750 -.0513 .141 $Neg wedge (6)
32 p0000.0455 .143 -.0650 0.150 $1 plane (7)
c 33 p0000.0455 .143 .0650 0.150 $11 plane (8)
c 34 p000.0663 0.1500 -.0455 .143 $111 plane(9)
35 p0000 -.0455 .143 -.0650 0.150 $IV plane (10)33
36 p000 -.00825 .0513 .141 -.0815 0.150 $1' plane (11)
c 37 p000.00825 .0513 .141 .08150.150 $11' plane (12)
c 38 p000.00825 -.0513 .141 .08150.150 $111' plane (13)
39 p000 -.00825 -.0513 .141 -.0815 0.150 $IV' plane (14)
21 so 7
C Collimator/Detector Surfaces
20 pz -3.0925 $Top of Lucite (3/4" = 1.905 cm thick)
24 c/z .03750 2.54 $Radius of collimator I Ito z-axis(x,y,R)
25 c/z .03750.05 $Rad of collimator openingi Ito z-axis (x,y,R)
26 pz -1.1875 $Division between scintillator and copper (3/8")
27 pz -.235 $Copper collimator .08 cm above stent
28 c/z .0375 0.05 $Radius of scintillator to z-axis (x,y,R)
29 pz -2.775 $Top of scintillator (5/8" = 1.5875 cm)
Mode PE
Phys:E 2.849 $Max energy cut-off for Mn-56 electrons (MeV)
imp:p 11111111111011111
C(x y z)(x,x' y,x' z,x')(x,y' y,y' z,y')(x,z' y,z' z,z')
C Cell translations in degrees (the asterisk)
C For cells 2 and 3
*TR1000090 90 90 -120 210 90 -30 120
*TR2000090 90 90 -240 330 90 -150 240
C For cells8 and 9
*TR3 000090 90 90 -120 210 90 -30 120
*TR4 000090 90 90 -240 -30 90 -150 240
C For cells 5 and 6
*TR5 0000 90 90 90 120 -210 -90 30 -120
*TR6 000090 90 90 240 -330 -90 150 -240
C Materials:
C Carbon Steel (Density=7.82 g/cm3)
ml 6000.005 $C
26000 -.995 $Fe
CAir (Derisity=.00l20479 g/cm3)
m2 6012.000124 $C
7000.755267 $N
8016 -.231781 $0
18000.012827 $Ar
CStainless steel tube-3l6L (Density=8.00 g/cm'3)
m3 6000 .0003 $C
25055 .02 $Mn
15031 .00045 $P
16000 .0003 $S
14000 .01 $Si
24000 .17 $Cr
28000 .12 $Ni
42000 .025 $Mo
26000 .65395 $Fe
CLucite (Density=l.19 g/cm3)
m4 1001.080538 $H
6012 -.599848 $C
8016 -.319614 $0
CPlastic Scintillator (Density=l.032 g/cm3)
mS 1001.085 $H
6012.915 $C
CCopper (Density=8.96 g/cm"3)
m6 29000 -1 $Cu
SDEFERG=Dl
P0s=0 00
CEL=D2 $Source Cells
WGT=92500 $2.5 uCi (1/12 of stent), no competing rad.
PAR=3 $Particle number for electron
RAD=D3
EXT=D434
AXS=l 00
EFF=.005 $This determines source sampling efficiency
c(lower limit); default=.0l
CA lower efficiency is needed for the source to work given its
c open
C geometry."
C Energies from Brown and Firestone, 1986
C Column 1: Energy bin boundaries; "h" for histogram
C Column 2: Relative intensities (%); "d" for discrete
SIl SP1
h d
o o
0.01 0.69
0.02 0.70
0.04 1.43
0.10 4.66
0.30 17.40
0.60 23.00
1.30 27.00
2.50 24.50
2.849 0.55
S12 L123456789 $Source cells
SP2 V 111111111 $"V" used only for cell distributions
SB2 D111111511 $Source biasing option
S13 .12499999 .13500001 $Inner and outer radii
S14 -.03500001 .07500001 $- and + length of cylinder (x-axis)
F8:E 24
*Fl8:E 24
E80.01 2481 2.5 $Spectrum starting at 10 key to 2.5 MeV
NPS 100000035
Appendix CDetection System Setup
Figure C. 1. The detector connected to the nuclear
instrumentation and oscilloscope.
Figure C.2. View of detector and PMT.36
Figure C.3. Apparatus used to hold and rotate stent.37
Figure C.4. Mounted stent over collimator as view under magnification.38
Figure C.5. Collimator opening (1 mm diameter) shown in comparison with the size of
the mounted stent.